Collaboration Agreements And Business Development Activities -Royalty Pharma Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 27, 2024 |
Sep. 29, 2023 |
Sep. 27, 2024 |
Sep. 29, 2023 |
|
Collaborative Arrangements with Glaxo Smith Kline | ||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
Percent of royalty on net sale | 3.00% | |||
Collaborative Arrangements with Royalty Pharma | ||||
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
Royalty expense | $ 19.7 | $ 17.5 | $ 54.8 | $ 50.2 |